Acetylsalicylic acid Completed Phase 4 Trials for Peripheral Arterial Disease (PAD) / Myocardial Infarction / Diabetes Mellitus (DM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02548650Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus
NCT00189618The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)
NCT01718288Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
NCT00793754Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
NCT01475552Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
NCT00915733Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism